한글목차

세계 장기 칩(Organ-on-a-Chip) 시장 규모는 2024년 1억 5,320만 달러에서 예측 기간 동안 33.6%의 연평균 복합 성장률(CAGR)로 2029년 말에는 6억 5,190만 달러에 달할 것으로 예상됩니다.

북미 시장은 2024년 6,750만 달러에서 예측 기간 동안 32.5%의 연평균 복합 성장률(CAGR)로 성장하여 2029년 말에는 2억 7,570만 달러에 달할 것으로 예상됩니다. 유럽 시장은 2024년 4,410만 달러에서 예측 기간 동안 35.1%의 연평균 복합 성장률(CAGR)로 성장하여 2029년 말에는 1억 9,880만 달러에 달할 것으로 예상됩니다.

세계의 장기 칩(Organ-on-a-Chip) 시장을 조사했으며, 시장 개요, 시장 영향요인 및 시장 기회 분석, 법 및 규제 환경, 신기술 및 기술 개발 동향, 시장 규모 추이와 예측, 각종 부문별/지역별 상세 분석, 경쟁 구도, 주요 기업 개요 등의 정보를 전해드립니다.

목차

제1장 주요 요약

• 시장 전망
• 조사 범위
• 시장 요약
• 기술 진보
• 성장 촉진요인
• 부문 분석
• 결론

제2장 시장 개요

• Drug Discovery 시장의 잠재성
• 공급망
• Porter의 Five Forces 분석
• 전망

제3장 시장 역학

• 시장 역학 현황
• 시장 성장 촉진요인
• 동물 실험의 대체 수단
• 맞춤형 의료
• 시장 성장 억제요인
• 표준화 결여
• 멀티 장기 칩의 복잡성
• 시장이 해결해야 할 과제
• 고비용과 기술적 전문성 부족
• 임상 단계의 적은 응용
• 시장 기회
• 제약회사내 파트너십
• 미개척 조직 및 질병 모델

제4장 규제 상황

• 미국
• EU
• 중국
• 일본

제5장 신기술

• 요약
• 인체 칩
• AI와 예측 모델링
• 3D 프린팅
• 자동화와 지속적 모니터링

제6장 시장 부문 분석

• 세분화 내역
• 제품 및 서비스
• 장기 칩
• 디바이스
• 소프트웨어
• 서비스
• 시장 분석 : 용도별
• Drug Discovery & Development
• 독성학 조사
• 생리학적 모델 개발
• 시장 분석 : 최종사용자별
• 바이오테크놀러지 및 제약회사
• 학술연구기관
• 화장품 회사
• 기타
• 지역 분석
• 시장 분석 : 지역별
• 북미
• 유럽
• 아시아태평양
• 남미
• 중동 및 아프리카

제7장 경쟁 정보

• 경쟁 분석
• 파트너십
• 인수합병(M&A) 활동
• 자금조달
• 특허 상황
• 특허 리뷰 : 관할별

제8장 부록

• 조사 방법
• 출전
• 약어
• 기업 개요
• 4DCELL
• AXOSIM
• BEONCHIP
• BIOIVT
• BIOMIMX S.R.L.
• CHERRY BIOTECH
• CN BIO INNOVATIONS LTD.
• ELVEFLOW
• EMULATE INC.
• INSPHERO
• KIRKSTALL LTD.
• MIMETAS B.V.
• QURIS TECHNOLOGIES LTD.
• SYNVIVO INC.
• TISSUSE GMBH
• 기타 주요 기업

영문목차

The global Organ-on-a-Chip market is expected to grow from $153.2 million in 2024 and is projected to reach $651.9 million by the end of 2029, at a compound annual growth rate (CAGR) of 33.6% during the forecast period of 2024 to 2029.

The North American Organ-on-a-Chip market is expected to grow from $67.5 million in 2024 and is projected to reach $275.7 million by the end of 2029, at a CAGR of 32.5% during the forecast period of 2024 to 2029.

The European Organ-on-a-Chip market is expected to grow from $44.1million in 2024 and is projected to reach $198.8 million by the end of 2029, at a CAGR of 35.1% during the forecast period of 2024 to 2029.

Report Scope:

This report analyzes trends in the global organ-on-a-chip (OoC) market. The market is segmented based on products and services, applications, end users, and regions. The application segment is characterized by drug discovery and development, toxicological research, and physiological model development. End-users include academic and research institutes, pharmaceutical and biotechnology companies, and the cosmetics industry. Products and services include organ chips, instruments, software, and services. Organ chips are further segmented into single-organ and multi-organ-on-a-chip products. The single-organ-on-a-chip products are further sub-segmented into liver, lung, heart, kidney, and other organs.

The report focuses on the major trends and challenges that affect the market and vendor landscape. It analyzes patents and emerging technologies related to the market. The report includes an analysis of the competitive landscape and industry structure and concludes with profiles of the leading companies.

In this report, the OoC market is segmented by geographical region into North America, Europe, Asia Pacific, South America, and the Middle East and Africa (MEA). The North American region consists of the U.S., Canada, and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea, Australia and the Rest of Asia-Pacific. The report covers global revenue ($ millions) for the base year of 2023, estimated data for 2024, and forecast values for 2025 through 2029.

Report Includes:

• 77 data tables and 53 additional tables
• Analyses of trends in the global organ-on-a-chip (OoC) market, with revenue data for 2021 to 2023, estimates for 2024, as well as projected CAGRs through 2029
• Estimates of the market size and revenue prospects for the global market, along with a market share analysis by product and service, application, end user and region
• Facts and figures pertaining to the market dynamics, technological progress, innovations, prospects, regulations and the impact of various macroeconomic factors
• A look at why organ-on-a-chip technology is gaining traction as an alternative to animal testing in life science research, toxicology testing and drug development studies
• Insights derived from the Porter's Five Forces model, as well as global supply chain and PESTLE analyses
• Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, and the ESG scores and practices of leading companies
• Analysis of the industry structure, including companies' market shares and rankings, strategic alliances, M&A activity and a venture funding outlook
• Profiles of leading companies, including Emulate Inc., Mimetas, TissUse GmbH, InSphero AG, and CN Bio Innovations Ltd.

Table of Contents

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Market Summary
• Technological Advances
• Drivers of Growth
• Segmental Analysis
• Conclusion

Chapter 2 Market Overview

• Introduction
• Market Potential in Drug Discovery
• Supply Chain
• Raw Materials Suppliers
• Manufacturers
• Distributors
• End Users
• Porter's Five Forces Analysis
• Potential for New Entrants
• Threat of Substitutes
• Bargaining Power of Suppliers
• Bargaining Power of Buyers
• Degree of Competition
• Outlook

Chapter 3 Market Dynamics

• Market Dynamics Snapshot
• Market Drivers
• Animal Testing Alternatives
• Personalized Medicine
• Market Restraints
• Lack of Standardization
• Complexity of multi-Organ-on-a-Chip
• Market Challenges
• High Cost and Lack of Technical Expertise
• Few Applications in Clinical Stages
• Market Opportunities
• Partnerships within Pharmaceutical Companies
• Unexplored Tissue and Disease Models

Chapter 4 Regulatory Landscape

• U.S.
• European Union
• China
• Japan

Chapter 5 Emerging Technologies

• Takeaways
• Body-on-a-Chip
• AI and Predictive Modeling
• 3D Printing
• Automation and Continuous Monitoring

Chapter 6 Market Segment Analysis

• Segmentation Breakdown
• Products and Services
• Organ Chips
• Devices
• Software
• Services
• Market Analysis by Application
• Drug Discovery and Development
• Toxicological Research
• Physiological Model Development
• Market Analysis by End User
• Biotech and Pharmaceutical Companies
• Academic and Research Institutes
• Cosmetics Companies
• Other End Users
• Geographic Breakdown
• Market Analysis by Region
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

Chapter 7 Competitive Intelligence

• Competitive Analysis
• Partnerships
• M&A Activity
• Funding
• Patent Landscape
• Patent Review by Jurisdiction

Chapter 8 Appendix

• Methodology
• Sources
• Abbreviations
• Company Profiles
• 4DCELL
• AXOSIM
• BEONCHIP
• BIOIVT
• BIOMIMX S.R.L.
• CHERRY BIOTECH
• CN BIO INNOVATIONS LTD.
• ELVEFLOW
• EMULATE INC.
• INSPHERO
• KIRKSTALL LTD.
• MIMETAS B.V.
• QURIS TECHNOLOGIES LTD.
• SYNVIVO INC.
• TISSUSE GMBH
• Other Key Players